Retinoblastoma — Trials

Retinoblastoma — Trials · CancerIndex

Clinical trials

Registered studies

110 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 15
Recruiting: 8
Ph III recruiting: 3
Growth YoY: —
Industry share: 7%
Top sponsor: Institut Curie
Termination share: —

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (16)

clinicaltrialsPublishedShowing 1–1 of 1 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT03026998	MRI Screening of Second Primary Cancer Occurring Within Radiation Fields After Treatment by External Beam Radiation Therapy for Hereditary Retinoblastoma (DepiSCARRH)(DepiSCARRH)	active not recruiting	N/A	88	Institut CurieOTHER	1	Sep 15, 2025	clinicaltrials

Data updated 23 days agoSource updated Sep 15, 2025source: clinicaltrials